Cannabis Investor NewsSubscribe →
C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
— —

IM Cannabis Corp.

—
—
Live Price

CIN RESEARCH · DATED EVIDENCE

Dated financial evidence

IM Cannabis Corp.: revenue contracted; examine the operating evidence.

The reported-period revenue series records CAD 7.59m for the period ended June 30, 2026. That is 40.2% below the same reporting basis a year earlier. Cash and operating cash flow are available on a matching dated basis.

Latest financial observation 2026-06-30Last reported price 2026-11-06Research checked 2026-11-06 13:30 UTC

The check time records a research refresh. Each financial figure and price keeps its own reporting date.

Compare like-for-like revenue

The reported-period revenue series records CAD 7.59m for the period ended June 30, 2026. That is 40.2% below the same reporting basis a year earlier.

Put cash beside operating cash flow

Period-end cash was CAD 1.74m at 2026-06-30. The matching reported-period operating cash outflow was CAD 1.32m. Later financing and cash movements are not established by this snapshot.

Follow the primary disclosures

The available record includes 2 primary disclosures. The latest is 2026-07-01. This is the available feed record, not a claim of complete filing coverage.

Reported financial evidence

Latest retained observation for each measure. Reporting periods and currencies can differ.
MeasureReported value & unitPeriod & intervalEvidence basis
RevenueCAD 7.59mUnit: CADQuarterly seriesDated financial series
Cost of revenueCAD 6.08mUnit: CADQuarterly seriesDated financial series
Gross profitCAD 1.51mUnit: CADQuarterly seriesDated financial series
Operating incomeCAD -2.09mUnit: CADQuarterly seriesDated financial series
EBITDACAD -966,671Unit: CADQuarterly seriesDated financial series
Cash balanceCAD 1.74mUnit: CADBalance at period endDated financial series
Total assetsCAD 24.73mUnit: CADBalance at period endDated financial series
Total liabilitiesCAD 30.37mUnit: CADBalance at period endDated financial series
Shareholders’ equityCAD -5.55mUnit: CADBalance at period endDated financial series
Operating cash flowCAD -1.32mUnit: CADQuarterly seriesDated financial series
Free cash flowCAD -1.32mUnit: CADQuarterly seriesDated financial series

A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.

What changed against the prior year

Only the same measure, unit, reporting frequency and prior-year period end are compared. A reported change is not an investment rating.

Revenue · Quarterly series

Decreased -40.2%

2025-06-30
CAD 12,696,000
2026-06-30
CAD 7,589,000
Cost of revenue · Quarterly series

Decreased -34.4%

2025-06-30
CAD 9,271,000
2026-06-30
CAD 6,084,000
Gross profit · Quarterly series

Decreased -56.1%

2025-06-30
CAD 3,425,000
2026-06-30
CAD 1,505,000
Operating income · Quarterly series

Decreased

2025-06-30
CAD -350,000
2026-06-30
CAD -2,090,000
EBITDA · Quarterly series

Decreased -148.2%

2025-06-30
CAD 2,007,000
2026-06-30
CAD -966,671
Cash balance · Balance at period end

Increased +119.6%

2025-06-30
CAD 794,000
2026-06-30
CAD 1,743,846
Total assets · Balance at period end

Decreased -39.8%

2025-06-30
CAD 41,068,000
2026-06-30
CAD 24,732,376
Total liabilities · Balance at period end

Decreased -17.9%

2025-06-30
CAD 37,007,000
2026-06-30
CAD 30,370,580
Shareholders’ equity · Balance at period end

Decreased -257.5%

2025-06-30
CAD 3,522,000
2026-06-30
CAD -5,548,056
Operating cash flow · Quarterly series

Decreased

2025-06-30
CAD -474,000
2026-06-30
CAD -1,318,326
Free cash flow · Quarterly series

Decreased

2025-06-30
CAD -450,840
2026-06-30
CAD -1,319,307

What to investigate next

  • Resolve the conflicting financial observations against the primary report.
  • Confirm the financial-statement currency against the original report; the listing currency is different.
  • Read the latest linked company disclosures and any reporting after the financial period.
  • Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.

Evidence boundaries

  • Conflicting observations for the same concept, period and reporting basis are withheld.
  • Financial-statement units differ from the listing currency. Values are kept in their reported units; valuation and cross-currency comparisons are withheld.
  • Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
  • The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.

Primary company disclosures

Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →

Price History · USD 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

CONTINUE YOUR RESEARCH

Connect the next piece.